10x Genomics (TXG) has been on my Compounding Healthcare “Bio Boom” speculative portfolio watch list since its IPO back in 2019. At that time, I was enthralled with their products, services, and R&D ...
10x Banking unveils the world’s first ‘meta core’ platform for banks – a fast, straight-forward and derisked path to full transformation LONDON--(BUSINESS WIRE)--10x Banking, the cloud-native core ...
10x Genomics (TXG) has quietly staged a comeback, with shares up sharply over the past month after a rough few years. Investors are reassessing whether the growth story is back on track. See our ...
10x Genomics has experienced a significant decline in share price, currently trading around $20 per share, with no bullish indicators for a potential reversal. Recent performance shows growth in total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results